Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02109848
Other study ID # OHSU IRB #00006612
Secondary ID R01EY018184
Status Completed
Phase
First received January 14, 2014
Last updated April 4, 2018
Start date June 2011
Est. completion date August 31, 2017

Study information

Verified date April 2018
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A prospective observational study on keratoconus and post-keratoplasty will be conducted. We will enroll 50 subjects in each of 3 groups: keratoconus, post-PK, and post-DSAEK. The Optovue anterior segment OCT prototype will be used to perform 3-D corneal scans. These scans will be used to measure corneal thickness (pachymetry), corneal topography (anterior and posterior) and epithelial thickness maps. The ultrahigh-speed MIT OCT prototypes will also be used when they become available. A comprehensive eye examination, Placido-ring corneal topography, ultrasound pachymetry, and Scheimpflug camera imagery, will be performed for comparison. In some post-PK and post-DSAEK cases, vision will be primarily affected by regular astigmatism, myopia, or hyperopia, rather than HOA. These cases can be corrected by standard PRK (not OCT guided) with adjunctive mitomycin C treatment to prevent haze formation.107, 108 In these cases PRK will be performed according to the standard of care and will not be a part of the study protocol. The postoperative results will be observed at the 3-4 month visit with UCVA, manifest refraction, BSCVA, OCT scanning, Placido topography, ultrasound pachymetry, and Scheimpflug camera imagery


Recruitment information / eligibility

Status Completed
Enrollment 7
Est. completion date August 31, 2017
Est. primary completion date August 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

• Adults (18 & older) with keratoconus, keratoplasty, DSAEK procedures

Exclusion Criteria:

- Inability to give informed consent.

- Inability to maintain stable fixation for OCT imaging.

- Inability to commit to required visits to complete the study.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Casey Eye Institute, Oregon Health & Science University Portland Oregon

Sponsors (3)

Lead Sponsor Collaborator
Oregon Health and Science University National Eye Institute (NEI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary validate OCT anterior topography The primary goal of this observational study is to validate OCT anterior topography by comparison with standard Placido-ring corneal topography 3-4 month